Clasp Therapeutics
Signal active
Organization
Contact Information
Overview
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type.
About
Industries
Biotechnology, Therapeutics
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Clasp Therapeutics headquartered in United States, North America, operates in the Biotechnology, Therapeutics sector. The company focuses on Biotechnology and has secured $1.2B in funding across 8 round(s). With a team of 11-50 employees, Clasp Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Clasp Therapeutics, raised $150.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
9
Lead Investors
0
Total Funding Amount
$150.0M
Details
1
Clasp Therapeutics has raised a total of $150.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 150.0M |
Investors
Clasp Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cure Ventures | - | FUNDING ROUND - Cure Ventures | 150.0M |
| Pictet Alternative Advisors | - | FUNDING ROUND - Pictet Alternative Advisors | 150.0M |
| Clasp Therapeutics | - | FUNDING ROUND - Clasp Therapeutics | 150.0M |
| Alexandria Venture Investments | - | FUNDING ROUND - Alexandria Venture Investments | 150.0M |
Recent Activity
There is no recent news or activity for this profile.